Stocks Finance And Beyond

Small-cap stocks have gotten a bad rap lately, and I get it. Most of them have severely underperformed the broader market rally we’ve seen. Sky-high interest rates have crushed the growth prospects for many of these fledgling companies. And let’s be real. A lot of small-caps are unprofitable anyway, so why even bother investing in

Broadcom’s (NASDAQ:AVGO) stock is an optimistic buy in line with high AI and networking capabilities. In fiscal Q2 2024, Broadcom had net revenue of $12.5 billion, a 43% year-over-year (YOY) increase. Excluding VMware, Broadcom’s revenue grew by 12%, primarily due to a 280% surge in AI revenue. Next year, Broadcom’s AI and networking revenue may grow 40%

Retail sales are a closely watched economic indicator every month. For the last year, the monthly and year-over-year (YOY) numbers have been weak at best. But there’s a bigger problem. The headline number doesn’t tell the full story of what ails retail stocks.   When adjusted for inflation, the retail sales numbers are negative. But you’re

Beauty stocks continue to shine as a lucrative investment opportunity, driven by consistent growth and innovation in the overall industry. The global cosmetics market is estimated to reach around $661 billion by 2032, increasing from $398 billion in 2023. That’s a compound annual growth rate (CAGR) of around 3.3% from 2024 to 2028, so the

If you’re looking for an index to buy-and-hold, you shouldn’t consider the Russell 2000. It makes no sense to follow a benchmark that has historically underperformed the S&P 500 and Nasdaq Composite for many years.  However, this same underperforming index offers great investment opportunities. Stocks often find themselves in the Russell 2000 long before they

Cannabis stocks have been through an extended period of depression. Overcapacity, regulatory headwinds, competition, and cash burn have contributed to the decline in the cannabis industry. However, markets react to extremes and I believe that cannabis stocks are undervalued. In addition to this, the regulatory environment is getting friendlier. Germany legalized recreational cannabis this year and I

Somewhat displaced by the association with shady cryptocurrencies, metaverse stocks and the broader metaverse universe should be viewed as a foundation in progress. It may or may not include alternate reality/virtual reality devices, but the building blocks are clear: GPUs, CPUs, content, content creation tools and blockchain tech at large for in-game digital assets. According

The IPO (initial public offering) market has gotten stronger in 2024, according to the Q2 2024 quarterly review from IPO specialist Renaissance Capital. That has resulted in a more buoyant market for secondary offerings.  According to Renaissance, 39 IPOs raised nearly $9 billion in the second quarter, 35% higher than Q2 2023 and 324% higher

As we enter August, it’s time to start thinking about autumn. Back-to-school sales are on and it won’t be long before the days get shorter and the temperature grows colder. Of course, the stock market has been anything but tranquil this summer. Volatility continues to rule as investors shift money around and equities swing from

The growth and tech-heavy Nasdaq 100 index is in something of a significant correction at the moment. After hitting new all-time highs early in July, the benchmark Invesco QQQ ETF (NASDAQ:QQQ) has already pulled back close to 10% from its recent peak. There are several reasons for this. Several key tech leaders, such as Amazon

Sometimes the best way to jump into an industry like biotech is to follow the popular trades. Though that may go against the common advice of avoiding hype cycles and the fear of missing out, seeing which biotech stocks are experiencing the highest 24-hour trading volumes can be a quick way to learn which catalysts

At age 93, Warren Buffett presides over a vast stock portfolio currently worth nearly $400 billion. From humble beginnings, Buffett has created an equity portfolio that is the envy of the investment world. It is carefully tracked, meticulously analyzed and hotly debated by analysts, investors and media pundits. Many people try to replicate the Oracle

Investing in biotech stocks is a thrilling ride. These innovative businesses developing breakthrough drugs can generate enormous profits for investors but also destroy significant value if their investigational therapies fail to make it to market. The pandemic focused a lot of attention on the sector. The SDPR S&P Biotech ETF (NYSEARCA:XBI) soared 49% in 2020,

There is no debating that stock market valuations are sky high right now. While the Federal Reserve hinted at rate cuts in September at its latest Federal Open Market Committee (FOMC) meeting, that doesn’t mean that stocks are setting up for new highs. Investors searching for safe stocks for a bear market should start their preparation

One of the goals of investing should be to put your portfolio on autopilot. Fill it with quality companies and then set it and forget it. The benefit of the strategy is it removes the temptation to trade in and out of stocks. JPMorgan Asset Management found that over the 20-year period between January 2003

In the fast-paced world of investing, it’s rare to find low-cost growth stocks to buy and hold for the long term. Low-cost growth stocks are often found in sectors with high growth potential. For example, in the general tech industry or in more niche sectors like biotechnology. These stocks offer the possibility of substantial returns